TABLE 1.

Oligonucleotide primers used in this study^a

Primer name	Sequence (5′-3′)	Gene	Positionsb	Reference
PR8F	CCCATTCTTCCCTGTTCCAT	prnA	81–100	15
PF	TGTCTCTGTCACGCATTGTC	prnA	152–171	17
AF	GCCAATGTCACGGTCCAA	prnA	649–666	17
PRN707R	AGGGCGCCGATATGCAAG	prnA	707–690	This study
PRN1157F	CACCGCACGGCAATGTCAT	prnA	1157–1175	This study
AR	GCAAGGTGATCGACAGGG	prnA	1234–1217	17
BF	AGCTGGGCGGTTCAAGGT	prnA	1542–1559	17
PRN1618R	GGTCCGCGAAGACATTCAT	prnA	1618–1600	This study
PRN8	AGGGTAAAGGTCGCCGCGCT	prnA	1763–1744	5
PRN1976F	ACGCGGCGGTCAACACG	prnA	1976–1992	This study
BR	CGGATTCAGGCGCAACTC	prnA	2076–2059	17
PRN2413F	GGCAAGTACCGCACCCAT	prnA	2413–2430	This study
PRNF1	CAGTTCGATGCGCTTGCC	prnA	2628–2611	5
PR	ATGCCGTTGGTGTGTACCGT	prnA	2714–2695	17
PR5R	GCCTGAGCCTGGAGACTGG	prnA	2949–2931	15
S1F	TAGGCACCATCAAAACGCAG	ptxA	474–493	17
S1FM	ACAATGCCGGCCGTATCCTC	ptxA	946–965	17
S1R	TCAATTACCGGAGTTGGGCG	ptxA	1350–1331	17

^aOligonucleotide primers used for amplification and sequencing of the pertactin and pertussis toxin genes of B. pertussis. 

^bThe positions of the prnA primers are according to the numbering of the B. pertussis prnA sequence (GenBank accession number J04560) and of the ptxA primers are according to the numbering of the ptxA sequence (accession number M14378).